COMMUNIQUÉS West-GlobeNewswire

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Notice to Convene the Annual General Meeting of Genmab A/S
18/02/2026
Company Announcement Genmab A/S to hold Annual General Meeting on Thursday March 19, 2026 COPENHAGEN, Denmark; February 18, 2026 – Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Thursday, March 19, 2026 [...]
Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
18/02/2026
Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung Cancer Trial is fully funded by the U.S. Department of Veterans Affairs and is open for enrollment at 11 VA [...]
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
18/02/2026
Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 million IM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR Milestone Strategic Transformation [...]
Theriva™ Biologics Licenses SYN-020 to Rasayana Therapeutics for Multiple Indications
18/02/2026
- Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales milestones along with tiered single-digit royalties on net product sales - - Rasayana to [...]
Stoked Bio Secures Exclusive Global License to Develop a Promising New Therapy for Crohn’s Disease
18/02/2026
Enterololin, a narrow-spectrum antibiotic uses a novel mechanism of action to attack the infection HAMILTON, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Stoked Bio Inc., a Canadian biotechnology company focused on the [...]
Design Therapeutics to Participate in Upcoming Investor Conferences
18/02/2026
CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]
Imprivata Patient Access Now Available in Epic Toolbox for Identity Verification in MyChart
18/02/2026
Integration strengthens patient identification across all points of care, enhancing PHI security, reducing duplicate medical records, and lowering costs tied to denied or fraudulent claims WALTHAM, Mass., Feb. 18, 2026 [...]
Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics
18/02/2026
Collaboration will harness UNP’s AI enhanced macrocycle platform to drug historically “undruggable” targets SANTA CRUZ, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing [...]
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
18/02/2026
Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced on February 18, 2026 NEW YORK, Feb. 18, 2026 (GLOBE [...]
Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio
18/02/2026
Patent strengthens protection for novel PTSD drug and advances the Company’s international IP strategy SARASOTA, FL, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a [...]
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
18/02/2026
OSHA standardizes on Mesa’s DryCal Defender technology for field enforcement as industry faces generational knowledge gap in flow calibration LAKEWOOD, Colo., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. ( [...]
Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
18/02/2026
Tumor Shrinkage of 50% and significant CA-125 biomarker reduction observed at 220 mg dose level Patient experienced only Grade 1 adverse events Represents second patient with PR to harbor PPP2R1A mutation, supporting [...]
GLP-1 Usage Increases 67% While Bariatric Surgeries Decline, but Long-Term Benefits Remain Unclear
18/02/2026
GREENWICH, Conn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- A new analysis by Cedar Gate Technologies , an IQVIA business (Cedar Gate), found a 13% decline in bariatric surgery volume over the past year, alongside a 67% [...]
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
18/02/2026
BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer [...]
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
18/02/2026
CLEARWATER, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body [...]
Aspargo Labs Appoints Sam Backenroth as Chief Financial Officer
18/02/2026
Adds experienced public-company finance executive to advance Aspargo’s corporate, commercial, and capital markets strategies NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company [...]
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
18/02/2026
SAN DIEGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA [...]
Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform
18/02/2026
Worcester, Massachusetts, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST ), a diversified innovation company with operations spanning eco-friendly products and collectibles monetization, today [...]

Pages